a/Prof Anthony Sasse is a consulting Pulmonologist in rural Australia who saw first the power of the tetanus toxin molecule whilst working in a remote hospital in India, where he treated many cases of Tetanus.
He has held the position of Director of Intensive Care and Director of Sleep study Diagnostic units in Australia, served a tour of duty with the Australian Army and attends the Presbyterian Church. He has published many articles in the field of sleep medicine, including the identification of venlafaxine as a useful drug in cataplexy. He holds an adjunct Professorship at RMIT University, Melbourne, Australia, and is responsible for the inception of this project; the development of novel tetanus toxin molecules for human and veterinarian use in low tone muscle disorders such as snoring, sleep apnoea, cosmetic muscle toning, ectropion and ptosis, sphincter and pelvic floor muscle toning, and general limb muscle toning.